Asthma (Diagnosis)REACHNCT07819747
Resources and Education for Addressing Chronic Health (REACH)
A study testing REACH in people with Asthma (Diagnosis), run by Washington University School of Medicine at 1 site in United States.
Trial summary
This study pilots REACH, Resources and Education for Addressing Chronic Health, a service model to facilitate care coordination and communication across medical, school, and home settings. Read more about this study
- Who is it for?
- Ages 3 to 18 years
- Conditions the study is for
- Asthma (Diagnosis)
- What is being tested?
- REACH
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 430 participants
- Where
- 1 siteUnited States
- Study dates
- 9 Jun 2026to Jun 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- parents/caregivers with at least one child with asthma or present to the nurse with asthma symptoms in the partner school district,
- child with asthma must have a diagnosis of asthma or suspected asthma due to asthma symptom-related healthcare utilization and/or multiple visits to the school nurse (>1)
- attend a school in one of the partner school districts
- have access to email and a computer or other mobile device
- receive care within the BJH/ WUSM system (an indicator of participation in the electronic health record system).
- Employed by partner school district and work in an identified building
- Provide care to students with asthma or present with asthma symptoms
- Provide care to a child participant on the study
Who cannot join
- Child does not have asthma and do not present to school nurse with asthma symptoms
- Child does not attend one of the identified schools in a partner school district
- Children in foster care or wards of the state
- School Nurses (Implementers) (N=15)
- Do not work for partner school district or for an identified building
- Providers (N =15)
- Do not provide care to a child participant on the study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
WashU School of Medicine
St Louis, Missouri, 63110
Madelyn Yoo, MSOT, 314-400-8118, m.g.yoo@wustl.edu
About this study
Official title: Piloting REACH - a School-Based Care Coordination Service Model to Support Youth With Asthma: A Systems Approach
This study pilots REACH, Resources and Education for Addressing Chronic Health, a service model to facilitate care coordination and communication across medical, school, and home settings. REACH seeks to address barriers to school-based asthma management, improving health and educational outcomes and reducing negative impacts for children with asthma.
Read the detailed description
This study develops and tests the REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resources, and (c) a tool/hub that allows record and communication sharing across healthcare and educational systems to facilitate care coordination. Using a Single-Arm Non-Randomized Pre-Post Cluster Trial design, this study tests the hypothesis that use of a care coordination hub will improve school-based asthma management.
- Conditions
- Asthma (Diagnosis)
- Being tested
- REACH
- Keywords
- Asthma, child health, patient care management, nursing, health services research
- Medical subject headings
- Asthma, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
REACHOther
The REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resource provided both digitally and in-person, and (c) a tool or dashboard that allows records and communication sharing across healthcare and educational systems to facilitate care coordination (REACH tool).
| Study group | Role | What they receive |
|---|---|---|
| REACH | Experimental | Consists of school nurses who serve as both participants and REACH intervention implementers, students and their caregivers, and student providers. Though there are several participant types, there is only 1 experimental group. All participants serve as their own controls. Receives: Other: REACH |
What is being measured
The primary outcome is the main question the study is designed to answer.
Asthma knowledge and awareness
Measured via survey. Data collected from student caregivers and school nurse implementers.
Measured: Measured at baseline and at study completion (average of 1 year)
Implementation
Measured via surveys and post-trial semi-structured focus group/interview. Data collected from student caregivers, school nurse implementers, and providers.
Measured: Measured at trial mid-point (approximately 6 months following enrollment) for school nurses only, and at study completion (average of 1 year) for all noted groups
Secondary outcomes (4)
Asthma guideline adherence
Measured via survey. Data collected from student caregivers and school nurse implementers.
Measured: Measured at baseline and at study completion (average of 1 year)
School connectedness
Measured via survey. Data collected from student caregivers.
Measured: Measured at baseline and at study completion (average of 1 year)
Healthcare utilization
Number of asthma related emergency department visits, hospitalizations, and clinic/office visits collected from the electronic medical record.
Measured: 24 months prior to intervention, during intervention, and 12 months following intervention completion
School Attendance/Absence
Number of days student is attends school, and number of school absence days. Data provided by the school.
Measured: 24 months prior to intervention, during intervention, and 12 months following intervention completion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2026
- Study start9 Jun 2026
- Primary completionJun 2030 (estimated)
- Study completionJun 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Asthma (Diagnosis)Studies of the same condition, open and under way.
- More trials run by Washington University School of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 430 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kelly Harris, Washington University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07819747
- Sponsor's protocol ID
- 202605145
- Other IDs
- SCH205081
- Acronym
- REACH
- Status last verified
- Sep 2026
- First submitted
- 1 Sep 2026
- Last updated
- 21 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all IPD that underlie results in a publication
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Piloting REACH - a School-Based Care Coordination Service Model to Support Youth With Asthma: A Systems Approach
- ClinicalTrials.gov ID
- NCT07819747
- Acronym / sponsor ID
- REACH / 202605145
- Conditions
- Asthma (Diagnosis)
- Keywords
- Asthma, child health, patient care management, nursing, health services research
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 430 participants (estimated)
- Lead sponsor
- Washington University School of MedicineUniversity, hospital or other
- Study start
- 9 Jun 2026 (actual)
- Primary completion
- Jun 2030 (estimated)
- Study completion
- Jun 2030 (estimated)
- First posted
- 15 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study pilots REACH, Resources and Education for Addressing Chronic Health, a service model to facilitate care coordination and communication across medical, school, and home settings. REACH seeks to address barriers to school-based asthma management, improving health and educational outcomes and reducing negative impacts for children with asthma.
Detailed description
This study develops and tests the REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resources, and (c) a tool/hub that allows record and communication sharing across healthcare and educational systems to facilitate care coordination. Using a Single-Arm Non-Randomized Pre-Post Cluster Trial design, this study tests the hypothesis that use of a care coordination hub will improve school-based asthma management.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| REACH | Experimental | Other: REACHConsists of school nurses who serve as both participants and REACH intervention implementers, students and their caregivers, and student providers. Though there are several participant types, there is only 1 experimental group. All participants serve as their own controls. |
Who may qualify
- Ages
- 3 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (8 listed)
- parents/caregivers with at least one child with asthma or present to the nurse with asthma symptoms in the partner school district,
- child with asthma must have a diagnosis of asthma or suspected asthma due to asthma symptom-related healthcare utilization and/or multiple visits to the school nurse (>1)
- attend a school in one of the partner school districts
- have access to email and a computer or other mobile device
- receive care within the BJH/ WUSM system (an indicator of participation in the electronic health record system).
Key exclusion criteria (7 listed)
- Child does not have asthma and do not present to school nurse with asthma symptoms
- Child does not attend one of the identified schools in a partner school district
- Children in foster care or wards of the state
- School Nurses (Implementers) (N=15)
- Do not work for partner school district or for an identified building
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| REACHThe REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resource provided both digitally and in-person, and (c) a tool or dashboard that allows records and communication sharing across healthcare and educational systems to facilitate care coordination (REACH tool). | Other | REACH |
Primary outcome
Asthma knowledge and awareness
Time frame: Measured at baseline and at study completion (average of 1 year)
Measured via survey. Data collected from student caregivers and school nurse implementers.
Implementation
Time frame: Measured at trial mid-point (approximately 6 months following enrollment) for school nurses only, and at study completion (average of 1 year) for all noted groups
Measured via surveys and post-trial semi-structured focus group/interview. Data collected from student caregivers, school nurse implementers, and providers.
4 secondary outcomes
Asthma guideline adherence
Time frame: Measured at baseline and at study completion (average of 1 year)
School connectedness
Time frame: Measured at baseline and at study completion (average of 1 year)
Healthcare utilization
Time frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
School Attendance/Absence
Time frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2026.
- Individual participant dataSharing planned: Yes. all IPD that underlie results in a publication
Related trials for Asthma (Diagnosis)
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
RecruitingPhase 3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing REACH in people with Asthma (Diagnosis), run by Washington University School of Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dr. Kelly M. Harris, PhD, CCC-SLP (314-273-3242, kmharris@wustl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Asthma knowledge and awareness (time frame: Measured at baseline and at study completion (average of 1 year)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.